NEXGEL, Inc. (NXGL): history, ownership, mission, how it works & makes money

A Brief History of NEXGEL, Inc. (NXGL)

Foundation and Early Years

NEXGEL, Inc. was founded in 2018, primarily focusing on the development of innovative hydrogel products. The company specializes in creating advanced gel technology solutions for healthcare, personal care, and consumer products.

Public Listing and Financial Growth

NEXGEL went public on March 24, 2021, through a reverse merger with a publicly traded company, achieving a listing on the OTCQB under the ticker symbol NXGL.

As of December 31, 2021, NEXGEL reported total assets of approximately $3.1 million, with total liabilities amounting to $4.3 million.

Product Development and Partnerships

NEXGEL has developed various products, including their flagship product, the SmartGel Technology, which is used across multiple applications such as wound care and medical devices. In 2021, they entered into strategic partnerships with several healthcare firms to enhance their product reach.

Recent Financial Performance

For the fiscal year 2022, NEXGEL announced total revenues of $3.6 million, marking a notable increase from previous years. The cost of goods sold for the same year was reported at approximately $2.1 million, resulting in a gross profit of $1.5 million.

Future Outlook

NEXGEL has forecasted an optimistic growth trajectory, projecting revenues to potentially reach $5 million by the end of 2023, driven by expanding their product lines and entering new markets.

The company continues to invest in research and development, focusing on innovative applications for their hydrogel technology in the fields of healthcare and agriculture.

A Who Owns NEXGEL, Inc. (NXGL)

Shareholder Structure

NEXGEL, Inc. (NXGL) has a diverse ownership structure comprising institutional investors, individual shareholders, and company insiders. As of the latest data from October 2023, the company had the following distribution of ownership:

Major Institutional Shareholders

The largest institutional shareholders of NEXGEL, Inc. include:

Executive Team and Insider Ownership

The executive team and board members have significant stakes in the company:

Recent Stock Performance

As of October 2023, NEXGEL, Inc. (NXGL) stock performance metrics are as follows:

Conclusion on Ownership Dynamics

The ownership of NEXGEL, Inc. is characterized by a mix of institutional and individual investors, with a notable portion held by insiders, reflecting confidence in the company's future prospects. The diverse ownership structure positions NXGL for robust strategic initiatives moving forward.

NEXGEL, Inc. (NXGL) Mission Statement

Company Overview

NEXGEL, Inc. (NXGL), founded in 1996, is a leading provider of hydrophilic and hydrogel products primarily for the healthcare and consumer markets. The company's mission revolves around innovation, enhancing user experiences, and improving the quality of life through its advanced gel products.

Mission Statement

NEXGEL aims to deliver high-quality, innovative gel-based solutions that empower healthcare professionals and enhance the well-being of patients. The company commits to sustainability, quality, and excellence in all its product offerings.

Core Values

• Innovation
• Quality
• Integrity
• Sustainability
• Customer Focus

Financial Highlights

NEXGEL has shown consistent growth in revenue and market presence. As of the latest fiscal year, the company reported the following financial metrics:

Market Position

NEXGEL has established itself in various sectors, including:

• Healthcare: Focus on advanced wound care and drug delivery systems.
• Consumer Products: Gel-based personal care items.
• Industrial Applications: Custom gel solutions for various industries.

Product Categories

The company specializes in diverse product lines, which include:

Strategic Initiatives

NEXGEL's strategic initiatives to drive growth and enhance its market presence include:

• Investment in R&D for innovative product development.
• Expansion into international markets.
• Partnerships with leading healthcare organizations.
• Enhancing production capabilities to meet market demand.

Sustainability Commitment

The company is dedicated to sustainable practices, focusing on:

• Reducing carbon footprint in manufacturing.
• Using environmentally friendly materials.
• Implementing a recycling program for all products.

Recent Achievements

In the recent fiscal period, NEXGEL has achieved significant milestones:

Future Directions

The future directions for NEXGEL include:

• Advancing the technology behind hydrogel products.
• Exploring new markets and applications for existing products.
• Enhancing customer engagement through feedback and innovation.

How NEXGEL, Inc. (NXGL) Works

Business Model

NEXGEL, Inc. operates primarily in the healthcare sector, focusing on the development and commercialization of innovative gel-based products.

Product Lines

• Medical Products
• Consumer Products
• Technology Products

Financial Performance

As of the latest financial reports, NEXGEL's revenue for the fiscal year ended December 31, 2022, was approximately $4.56 million.

The company reported a net loss of about $4.8 million for the same period.

Stock Performance

As of October 2023, NEXGEL's stock price (NXGL) is listed at approximately $0.60 per share.

The market capitalization of the company is roughly $8.5 million.

Research and Development

For the fiscal year of 2022, NEXGEL allocated about $1.2 million towards research and development expenses.

Strategic Partnerships

NEXGEL has formed partnerships with various entities including:

• Healthcare providers
• Research institutions
• Pharmaceutical companies

Market Segmentation

Current Initiatives

NEXGEL is actively involved in several initiatives including:

• Expansion of product lines
• Enhancing manufacturing capabilities
• Increasing market presence

Corporate Governance

The Board of Directors consists of five members, with a mix of experienced professionals in the fields of finance, healthcare, and operations.

Future Outlook

Analysts project a revenue growth rate of approximately 20% annually over the next five years for NEXGEL, driven by an increase in demand for their gel-based products.

How NEXGEL, Inc. (NXGL) Makes Money

Product Revenue

NEXGEL, Inc. generates revenue primarily through the manufacturing and selling of hydrogel products. The company's offerings include various applications particularly in the medical and consumer markets.

Key Product Lines

• Hydrogel for wound care
• Hydrogel for personal care and cosmetics
• Drug delivery systems

Financial Performance

As of the latest financial statements, NEXGEL reported:

Research and Development

The company invests in R&D to expand its product line. In 2022, NEXGEL allocated approximately $1.0 million toward R&D initiatives aimed at enhancing hydrogel technology.

Partnerships and Collaborations

NEXGEL has established various partnerships which have helped in expanding its market reach. For example:

• Partnership with a leading pharmaceutical company for drug delivery systems
• Collaboration with cosmetic brands for hydrogel-infused products

Market Segmentation

NEXGEL operates in several market segments:

Sales Strategy

The company employs multiple sales channels including:

• Direct sales to hospitals and clinics
• Distribution agreements with medical supply companies
• Online sales platforms

Cost Structure

NEXGEL's cost structure primarily consists of:

• Raw materials for hydrogel production
• Manufacturing overheads
• Marketing and distribution expenses

Operational Highlights

As of the latest report, NEXGEL operates out of a facility capable of producing over 1 million units of hydrogel products annually.

Future Growth Projections

NEXGEL anticipates a revenue growth of approximately 20-25% annually over the next five years due to increased demand for hydrogel products across various sectors.